Aytu BioPharma (Nasdaq: AYTU) is a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients.

This company webcast was recorded during the Lytham Partners Fall 2025 Investor Conference.